Growth Metrics

Marsh & Mclennan Companies (MRSH) EBIAT (2016 - 2025)

Marsh & Mclennan Companies (MRSH) has disclosed EBIAT for 17 consecutive years, with $821.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIAT rose 10.35% year-over-year to $821.0 million, compared with a TTM value of $4.2 billion through Dec 2025, up 3.59%, and an annual FY2025 reading of $4.2 billion, up 2.46% over the prior year.
  • EBIAT was $821.0 million for Q4 2025 at Marsh & Mclennan Companies, up from $727.0 million in the prior quarter.
  • Across five years, EBIAT topped out at $1.4 billion in Q1 2024 and bottomed at $503.0 million in Q4 2022.
  • Average EBIAT over 5 years is $907.4 million, with a median of $820.5 million recorded in 2021.
  • The sharpest move saw EBIAT soared 98.76% in 2021, then crashed 37.36% in 2022.
  • Year by year, EBIAT stood at $803.0 million in 2021, then plummeted by 37.36% to $503.0 million in 2022, then surged by 50.3% to $756.0 million in 2023, then decreased by 1.59% to $744.0 million in 2024, then increased by 10.35% to $821.0 million in 2025.
  • Business Quant data shows EBIAT for MRSH at $821.0 million in Q4 2025, $727.0 million in Q3 2025, and $1.2 billion in Q2 2025.